BD
-
BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
BD MiniDraw™ Capillary Blood Collection System Enables Lab-Quality Blood Testing from Less Invasive Method than Venous Collection in…
-
BD to Present Next Installment of BD Innovates Series: Spotlight on Pharmaceutical Systems
BD to Present Next Installment of BD Innovates Series: Spotlight on Pharmaceutical Systems
-
BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency
SiteRite™ 9 Ultrasound System Delivers Enhanced Image Quality and Vessel Assessment Tools to Aid in First Attempt IV…
-
BD Named Among the 100 Best Corporate Citizens of 2023
Company Ranks Top 2 in Healthcare Equipment and Services Industry
-
BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System
BD Alaris™ Infusion System is the only modular and most comprehensive infusion system on the U.S. market that…
-
BD Names Rishi Grover as Chief Integrated Supply Chain Officer
FRANKLIN LAKES, N.J., July 5, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global…
-
BD Collaborates with Mayo Clinic Platform, Leveraging Real-World Clinical Data to Improve Post-Market Device Surveillance, Drive Innovation for Patient Care
BD is among the first companies to enter innovative partnership with Mayo Clinic Platform for access to world’s…
-
CerTest Biotec and BD Announce Collaboration on Molecular Diagnostic Test for Monkeypox
CerTest Biotec Uses the BD MAX™ Molecular Diagnostic System Open System Reagent Suite to Develop RT-PCR Detection Kit
-
BD TO ACQUIRE PARATA SYSTEMS TO ENTER NEW PHARMACY AUTOMATION SOLUTIONS MARKET
Expands BD Transformative Solutions to Provide New Pharmacy Automation Technologies for Hospitals, Retail Pharmacy, Long-Term Care and Home…
-
BD Names William ‘Bill’ Brown to Board of Directors
BD Names William ‘Bill’ Brown to Board of Directors
-
BD Appoints Shana Neal as Chief People Officer
BD announced that Shana Neal has been appointed chief people officer.
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
